TGC Ventures International, Inc.
Not enough financial coverage to compute a composite score for TGVN. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Company
TGC Ventures International, Inc. operates early detection cancer clinics, using infra-red thermal imaging technology. The technology is used as diagnosis to determine structure changes in tissues to detect breast cancer.
- CEO
- Michael Woo
- IPO
- 2014
- HQ
- Atlanta, GA, US
Price Chart
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -63.93
- Avg Volume
- 0
Get TickerSpark's AI analysis on TGVN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our TGVN Coverage
We haven't published any research on TGVN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TGVN Report →